SUSAN R GEORGE
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical WICHITA, KS NPI 1821056797
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical KS Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$6,118.55
- Category: General Payments
- Program years: PY2021–2024
- Record count: 195
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $3,527.72 across 98 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,527.72 | 98 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $1,093.68 | 14 |
| ABBVIE INC. | $544.51 | 23 |
| ViiV Healthcare Company | $431.72 | 14 |
| Acerta Pharma LLC | $367.85 | 8 |
| EISAI INC. | $170.68 | 4 |
| Vanda Pharmaceuticals Inc. | $152.84 | 2 |
| Ardelyx, Inc. | $139.84 | 2 |
| Amgen Inc. | $97.41 | 1 |
| Napo Pharmaceuticals Inc | $79.85 | 3 |
| Exact Sciences Corporation | $74.85 | 4 |
| Merck Sharp & Dohme Corporation | $63.59 | 4 |
| PFIZER INC. | $58.53 | 3 |
| GlaxoSmithKline, LLC. | $53.61 | 3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $33.30 | 2 |
| Axsome Therapeutics, Inc. | $29.04 | 2 |
| Lilly USA, LLC | $27.47 | 2 |
| Recor Medical Inc | $18.31 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.11 | 1 |
| TOLMAR, INC. | $15.07 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.69 | 1 |
| Collegium Pharmaceutical, Inc. | $14.66 | 1 |
| Sumitomo Pharma America, Inc. | $14.33 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.78 | 1 |
By program year
Records — PY2024 (98)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.